ULIBDI

WIPO WIPO 2023

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ULIBDI was filed as Word mark on 02/21/2023 at the World Intellectual Property Organization.

Trademark Details Last update: August 9, 2023

Trademark form Word mark
File reference 1739717
Countries United Arab Emirates Australia Bosnia and Herzegovina Bahrain Brazil Canada Switzerland Chile China Colombia Cyprus Denmark Algeria Egypt European Community Finland Croatia Indonesia Israel India Iran Japan South Korea Lithuania Mexico Malaysia New Zealand Philippines Serbia Russia Sweden Singapore Thailand Turkey Ukraine Vietnam
Base trademark US No. 97560320, August 23, 2022
Application date February 21, 2023
Expiration date February 21, 2033

Trademark owner

3050 Science Park Rd.
San Diego CA 92037
US

Trademark representatives

1840 Century Park East, Suite 1900 Los Angeles CA 90067 US

goods and services

05 Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use
42 Medical laboratory services, namely, laboratory testing, medical diagnostic testing, evaluation, and medical research services; medical laboratory services, namely, laboratory testing in the field of disease management and pathology and of patient diagnosis and patient selection
44 Disease management services namely medical analysis services for diagnostic and treatment purposes and managing patient data; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to treatment recommendation; medical consultation; providing information about services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer via a websiter

Trademark history

Date Document number Area Entry
February 21, 2023 2023/26 Gaz US Registration

ID: 141739717